We are live on ! Find out more
AA

ALPS Advisors Portfolio holdings

AUM $21.3B
1-Year Est. Return 21.71%
This Fund
S&P 500
This Quarter Est. Return
+13.09%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$11.3B
AUM Growth
+$1.07B
Cap. Flow
-$113M
Cap. Flow %
-1%
Top 10 Hldgs %
43.92%
Holding
930
New
74
Increased
169
Reduced
352
Closed
28

Sector Composition

Rank Sector Weight
1 Energy 52.67%
2 Financials 10.26%
3 Technology 6.92%
4 Healthcare 4.76%
5 Consumer Discretionary 3.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FULT icon
401
Fulton Financial
FULT
$4.7B
$989K 0.01%
62,674
-3,253
-5% -$55.4K
ENTG icon
402
Entegris
ENTG
$19.7B
$965K 0.01%
7,850
-166
-2% -$19.1K
WSM icon
403
Williams-Sonoma
WSM
$26.7B
$953K 0.01%
11,944
-252
-2% -$21.4K
AOS icon
404
A.O. Smith
AOS
$8.38B
$949K 0.01%
13,177
-417
-3% -$28.8K
BTAI icon
405
BioXcel Therapeutics
BTAI
$26.2M
$943K 0.01%
2,027
-728
-26% -$397K
MPWR icon
406
Monolithic Power Systems
MPWR
$65.5B
$938K 0.01%
2,513
-55
-2% -$19.4K
ANAB icon
407
AnaptysBio
ANAB
$1.6B
$935K 0.01%
36,045
-13,429
-27% -$322K
CRNX icon
408
Crinetics Pharmaceuticals
CRNX
$8.86B
$933K 0.01%
49,516
-10,047
-17% -$177K
VSTM icon
409
Verastem
VSTM
$532M
$922K 0.01%
18,870
-6,727
-26% -$280K
AAT
410
American Assets Trust
AAT
$1.49B
$918K 0.01%
24,626
-1,278
-5% -$45.5K
CMRX
411
DELISTED
Chimerix, Inc.
CMRX
$908K 0.01%
113,549
+229
+0.2% +$1.9K
MGTX icon
412
MeiraGTx Holdings
MGTX
$1.09B
$904K 0.01%
+58,326
New +$834K
RGLD icon
413
Royal Gold
RGLD
$17.1B
$894K 0.01%
7,838
-73,266
-90% -$8.64M
CDE icon
414
Coeur Mining
CDE
$15.6B
$892K 0.01%
100,489
-769,022
-88% -$7.41M
STWD icon
415
Starwood Property Trust
STWD
$6.12B
$890K 0.01%
33,992
-1,764
-5% -$44.9K
ALBO
416
DELISTED
Albireo Pharma Inc
ALBO
$889K 0.01%
25,275
-9,306
-27% -$303K
CLNN icon
417
Clene
CLNN
$68.9M
$882K 0.01%
+3,923
New +$827K
KDMN
418
DELISTED
Kadmon Holdings, Inc.
KDMN
$877K 0.01%
+226,515
New +$878K
ADAP
419
DELISTED
Adaptimmune Therapeutics
ADAP
$872K 0.01%
204,775
-75,040
-27% -$364K
ICPT
420
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$872K 0.01%
43,680
-16,055
-27% -$318K
GGG icon
421
Graco
GGG
$12.9B
$871K 0.01%
11,504
-238
-2% -$17.9K
ALDX icon
422
Aldeyra Therapeutics
ALDX
$91.7M
$860K 0.01%
75,903
+5,676
+8% +$68.2K
WRK
423
DELISTED
WestRock Company
WRK
$860K 0.01%
16,158
-749
-4% -$41.9K
CTAS icon
424
Cintas
CTAS
$82.4B
$853K 0.01%
8,928
-180
-2% -$16K
NAVI icon
425
Navient
NAVI
$774M
$832K 0.01%
43,059
-2,235
-5% -$38.4K

Similar funds

ALPS Advisors's Q2 2021 Portfolio in Review

As of Q2 2021, ALPS Advisors held 930 positions worth $11.3B, up 10% from $10.2B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

ALPS Advisors's Q2 2021 filing shows 74 new, 169 increased, 352 reduced and 28 closed positions. Its largest new stake was ChargePoint: 61,396 shares worth $42.7M. The largest sale was Energy Transfer Partners, an estimated $77.7M.

By sector, the portfolio is most concentrated in Energy at 53% of assets, up from 50% a quarter earlier, followed by Financials and Technology.

  • ALPS Advisors's largest Q2 2021 buy was ChargePoint: 61,396 shares worth $42.7M.
  • ALPS Advisors added most to Enterprise Products Partners in Q2 2021, an estimated $37.6M increase.
  • ALPS Advisors's biggest Q2 2021 reduction was Energy Transfer Partners, cutting an estimated $77.7M.
  • ALPS Advisors fully exited Noble Midstream Partners LP in Q2 2021, selling an estimated $65.5M.
  • ALPS Advisors's ten largest holdings make up 44% of its $11.3B portfolio in Q2 2021.
  • ALPS Advisors opened 74 new positions and closed 28 in Q2 2021.
  • ALPS Advisors's portfolio value rose 10% quarter-over-quarter to $11.3B.

Based on ALPS Advisors's 13F filing for Q2 2021, filed 11 Aug 2021.